About Invicro
Invicro is a company based in Boston (United States) founded in 2008 was acquired by Calyx in March 2024. Invicro has raised $45.84 million across 3 funding rounds from investors including Konica Minolta, Calyx and HHS. The company has 308 employees as of December 31, 2022. Invicro has completed 2 acquisitions, including Imanova and Molecular NeuroImaging. Invicro offers products and services including Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry. Invicro operates in a competitive market with competitors including Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.
- Headquarter Boston, United States
- Employees 308 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$45.84 M (USD)
in 3 rounds
-
Latest Funding Round
$394 K (USD), Grant
Jun 01, 2016
-
Investors
Konica Minolta
& 2 more
-
Employee Count
308
as on Dec 31, 2022
-
Investments & Acquisitions
Imanova
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invicro
Invicro offers a comprehensive portfolio of products and services, including Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry.
Delivers high-quality imaging data for global clinical trials
Manages randomization and supply for efficient clinical studies
Supports imaging study designs in pharmaceutical development
Reviews trial event assessments for accurate outcomes
Radiolabels agents to aid in therapeutic research
People of Invicro
Unlock access to complete
Unlock access to complete
Funding Insights of Invicro
Invicro has successfully raised a total of $45.84M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $394 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invicro
Invicro has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Konica Minolta, Calyx and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRO providing imaging services for clinical development
|
Locked | Locked | Locked | |
|
Konica Minolta is engaged in providing imaging and printing solutions.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Invicro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invicro
Invicro has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Imanova and Molecular NeuroImaging.
Investment portfolio details for Invicro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
PET and MRI imaging services for drug development are provided.
|
Locked | Locked | 2011 | Locked | |
|
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Invicro
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Invicro
Detailed financials for Invicro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invicro Comparisons
Peer comparison for Invicro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invicro
Invicro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Perspectum, Qure.ai, IXICO, Zebra Medical Vision and Deeptek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicine software for liver disease diagnosis is offered.
|
|
| Locked | Locked | Locked |
AI-powered solutions for medical imaging diagnostics
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
|
| Locked | Locked | Locked |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| Locked | Locked | Locked |
AI-augmented diagnostic tools for radiology imaging are developed.
|
|
| Locked | Locked | Locked |
AI-driven solutions for medical diagnostic imaging are developed.
|
Detailed competitors of Invicro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invicro
Complete news archive for Invicro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invicro
Invicro was founded in 2008 and raised its 1st funding round 4 years after it was founded.
Invicro is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Invicro is a funded company, having raised a total of $45.84M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Invicro is 308.
Invicro was founded in 2008 and is headquartered in Boston, United States. Contract research organization services in medical imaging are offered to pharmaceutical and biotechnology companies throughout the drug development process. Coverage includes all imaging modalities and therapeutic areas such as neurology, oncology, systemic diseases, and rare conditions. Software platforms like VivoQuant, iPACS, and the IQ-Analytics suitewith tools including AmyloidIQ, TauIQ, and DaTIQare also provided for informatics support.
Invicro's top competitors include Perspectum, Qure.ai and Deeptek.
Invicro offers Imaging Core Lab, eClinical RTSM, Preclinical Imaging, Clinical Adjudication, and Radiochemistry.
Invicro has made 2 acquisitions, including Imanova, and Molecular NeuroImaging.
Invicro has 3 investors. Key investors include Konica Minolta, Calyx, and HHS.